Pharmadrug Inc. (PHRX.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 494.99 Thousand | 683.67 Thousand | 610.57 Thousand | - |
| Cost of Revenue | 26.21 Thousand | 2263.00 | 394.13 Thousand | 501.63 Thousand | 357.32 Thousand | - |
| Gross Profit | -26.21 Thousand | -2263.00 | 100.86 Thousand | 182.03 Thousand | 253.25 Thousand | - |
| Operating Expenses | 1.33 Million | 2.41 Million | 5.22 Million | 4.02 Million | 5.34 Million | 950.52 Thousand |
| Selling, General and Administrative Expenses | 1.1 Million | 1.68 Million | 3.38 Million | 2.87 Million | 3.39 Million | 950.52 Thousand |
| Research and Development Expenses | 226.35 Thousand | 712.68 Thousand | 553.76 Thousand | - | - | - |
| Other Expenses | - | 21.02 Thousand | 1.28 Million | 1.14 Million | 1.95 Million | - |
| Cost and Expenses | 1.33 Million | 2.42 Million | 5.61 Million | 4.52 Million | 5.7 Million | 950.52 Thousand |
| Operating Income | -1.33 Million | -2.42 Million | -5.1 Million | -3.81 Million | -5.09 Million | -3.32 Million |
| Interest Expense | - | 223.31 Thousand | 156.35 Thousand | 351.57 Thousand | 476.98 Thousand | 188.03 Thousand |
| Income Tax Expense | -1.01 Million | -190 Thousand | -833.54 Thousand | -389.07 Thousand | -442.74 Thousand | 2.74 Million |
| Earnings before Tax | -14.27 Million | -3.25 Million | -6.7 Million | -5.9 Million | -6.98 Million | -3.51 Million |
| Net Income | -13.2 Million | -3.06 Million | -5.87 Million | -5.51 Million | -6.53 Million | -3.88 Million |
| Earnings Per Share Basic | -0.23 | -0.06 | -0.12 | -0.27 | -0.65 | -0.28 |
| Earnings Per Share Diluted | -0.23 | -0.06 | -0.12 | -0.27 | -0.65 | -0.28 |
| Weighted Average Shares Outstanding | 56.48 Million | 50.09 Million | 47.31 Million | 20.35 Million | 10.01 Million | 13.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.48 Million | 50.09 Million | 47.31 Million | 20.35 Million | 10.01 Million | 13.74 Million |
| Gross Margin | - | - | 0.20 | 0.27 | 0.41 | - |
| EBIT Margin | - | - | -7.72 | -3.69 | -7.07 | - |
| Profit Margin | - | - | -11.87 | -8.06 | -10.71 | - |
| EBITDA | -1.33 Million | -2.34 Million | -4.2 Million | -4.28 Million | -5.72 Million | -2.39 Million |
| Earnings Before Tax Margin | - | - | -10.32 | -5.58 | -8.34 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 12.56 Thousand | 12.56 Thousand | 26.21 Thousand | 26.21 Thousand | - | - |
| Gross Profit | -12.56 Thousand | -12.56 Thousand | -26.21 Thousand | -26.21 Thousand | - | - |
| Operating Expenses | 49.86 Thousand | 436.89 Thousand | 1.61 Million | 2.31 Million | 204.13 Thousand | 283.47 Thousand |
| Selling, General and Administrative Expenses | 81.07 Thousand | 371.85 Thousand | 649.51 Thousand | - | 126.65 Thousand | 192.59 Thousand |
| Research and Development Expenses | -31.2 Thousand | 65.03 Thousand | 56.59 Thousand | - | 77.47 Thousand | 79.44 Thousand |
| Other Expenses | 562.00 | 774.00 | -904.14 Thousand | -904.14 Thousand | 483.00 | - |
| Cost and Expenses | 62.42 Thousand | 449.45 Thousand | 1.63 Million | 2.33 Million | 204.13 Thousand | 283.47 Thousand |
| Operating Income | -62.42 Thousand | -449.46 Thousand | -1.63 Million | -2.33 Million | -204.13 Thousand | -283.47 Thousand |
| Interest Expense | 82.15 Thousand | 92.46 Thousand | 168.24 Thousand | - | 21 Thousand | 73.73 Thousand |
| Income Tax Expense | -12.93 Thousand | -44.15 Thousand | -1.01 Million | -1.01 Million | -144.60 | -70.86 Thousand |
| Earnings before Tax | -144.01 Thousand | -541.14 Thousand | -13.37 Million | -14.27 Million | -300 Thousand | -419.97 Thousand |
| Net Income | -131.08 Thousand | -496.99 Thousand | -12.3 Million | -13.2 Million | -300 Thousand | -419.97 Thousand |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.21 | - | -0.04 | -0.01 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.21 | - | -0.04 | -0.01 |
| Weighted Average Shares Outstanding | 100.38 Million | 94.91 Million | 59.43 Million | 56.48 Million | 7.25 Million | 50.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 100.38 Million | 94.91 Million | 59.43 Million | 56.48 Million | 7.25 Million | 50.8 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -49.86 Thousand | -436.9 Thousand | -1.61 Million | - | -204.13 Thousand | -283.47 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
0HF9
0369
KANSHST
6648
003380
HAKI-B